Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients.
Breast cancer remains a major cause of death in women worldwide, and tumor metastasis is the leading cause of death in breast cancer patients after conventional treatment. Chronic inflammation is often related to the occurrence and growth of various malignancies. This study evaluated the prognosis o...
Main Authors: | Fang-Jing Ma, Zhe-Bin Liu, Xin Hu, Hong Ling, Shan Li, Jiong Wu, Zhi-Ming Shao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4216121?pdf=render |
Similar Items
-
Myeloid Differentiation Primary Response 88–Cyclin D1 Signaling in Breast Cancer Cells Regulates Toll-Like Receptor 3-Mediated Cell Proliferation
by: Aradhana Singh, et al.
Published: (2020-09-01) -
TcpC inhibits toll-like receptor signaling pathway by serving as an E3 ubiquitin ligase that promotes degradation of myeloid differentiation factor 88.
by: Jia-Qi Fang, et al.
Published: (2021-03-01) -
High mobility group box 1/toll-like receptor 4/myeloid differentiation factor 88 signaling promotes progression of gastric cancer
by: Yanqiu Yue, et al.
Published: (2017-03-01) -
Toll-like receptors and cancer: MYD88 mutation and inflammation
by: James Q Wang, et al.
Published: (2014-07-01) -
Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression
by: Qiaomei Dai, et al.
Published: (2018-01-01)